Furthermore, the cytotoxicity assay showed that dNK-RPL exhibited significantly higher cytotoxicity against JEG3 (a human trophoblast cell line with HLA-G expression) and K562 leukemia cells compared to dNK-NOR (Fig. 1F and Fig. S2). This evidence concerns the gene HLA-G and leukemia.